Home/Filings/4/0000950170-24-001971
4//SEC Filing

Tregoning Kathleen 4

Accession 0000950170-24-001971

CIK 0001701108other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:40 PM ET

Size

5.7 KB

Accession

0000950170-24-001971

Insider Transaction Report

Form 4
Period: 2024-01-02
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-02$1.12/sh+35,604$39,87635,604 total
    Exercise: $1.52Exp: 2034-01-02Common Stock (35,604 underlying)
Footnotes (2)
  • [F1]This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director.
  • [F2]This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $40,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy.

Documents

1 file

Issuer

Spero Therapeutics, Inc.

CIK 0001701108

Entity typeother

Related Parties

1
  • filerCIK 0001830764

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:40 PM ET
Size
5.7 KB